EE04415B1 - Antimükootilist toimet omava ühendi farmatseutiline peroraalne preparaat ja selle valmistamismeetod - Google Patents

Antimükootilist toimet omava ühendi farmatseutiline peroraalne preparaat ja selle valmistamismeetod

Info

Publication number
EE04415B1
EE04415B1 EEP200100041A EEP200100041A EE04415B1 EE 04415 B1 EE04415 B1 EE 04415B1 EE P200100041 A EEP200100041 A EE P200100041A EE P200100041 A EEP200100041 A EE P200100041A EE 04415 B1 EE04415 B1 EE 04415B1
Authority
EE
Estonia
Prior art keywords
compound
preparation
coat
antifungic
inert core
Prior art date
Application number
EEP200100041A
Other languages
English (en)
Inventor
Picornell Darder Carlos
Original Assignee
Liconsa, Liberacion Controlada De Sustancias Activas, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8304581&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE04415(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liconsa, Liberacion Controlada De Sustancias Activas, S.A. filed Critical Liconsa, Liberacion Controlada De Sustancias Activas, S.A.
Publication of EE200100041A publication Critical patent/EE200100041A/et
Publication of EE04415B1 publication Critical patent/EE04415B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
EEP200100041A 1998-07-21 1999-07-20 Antimükootilist toimet omava ühendi farmatseutiline peroraalne preparaat ja selle valmistamismeetod EE04415B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009801539A ES2157731B1 (es) 1998-07-21 1998-07-21 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
PCT/ES1999/000230 WO2000004881A1 (es) 1998-07-21 1999-07-20 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion

Publications (2)

Publication Number Publication Date
EE200100041A EE200100041A (et) 2002-06-17
EE04415B1 true EE04415B1 (et) 2005-02-15

Family

ID=8304581

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100041A EE04415B1 (et) 1998-07-21 1999-07-20 Antimükootilist toimet omava ühendi farmatseutiline peroraalne preparaat ja selle valmistamismeetod

Country Status (31)

Country Link
US (1) US6737082B1 (et)
EP (1) EP1103252B1 (et)
JP (1) JP4190732B2 (et)
KR (1) KR100572135B1 (et)
AT (1) ATE234077T1 (et)
AU (1) AU750730B2 (et)
BG (1) BG65187B1 (et)
BR (1) BR9912300A (et)
CA (1) CA2337509C (et)
CZ (1) CZ291938B6 (et)
DE (1) DE69905905T2 (et)
DK (1) DK1103252T3 (et)
EE (1) EE04415B1 (et)
ES (2) ES2157731B1 (et)
HK (1) HK1037531A1 (et)
HR (1) HRP20010128B1 (et)
HU (1) HU228895B1 (et)
IL (1) IL140910A (et)
ME (1) MEP26708A (et)
MX (1) MXPA01000681A (et)
NO (1) NO320054B1 (et)
NZ (1) NZ509886A (et)
PL (1) PL194740B1 (et)
PT (1) PT1103252E (et)
RS (1) RS50063B (et)
RU (1) RU2209628C2 (et)
SK (1) SK283279B6 (et)
TR (1) TR200100177T2 (et)
UA (1) UA64009C2 (et)
WO (1) WO2000004881A1 (et)
ZA (1) ZA200101293B (et)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69728379T2 (de) * 1996-01-31 2005-02-24 South Alabama Medical Science Foundation, Mobile Lebensmittel und vitamin herstellungen mit natürlichem isomeren von reduzierten folaten
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
EA006402B1 (ru) 1999-12-23 2005-12-29 Пфайзер Продактс Инк. Комбинация лекарства и целлюлозного полимера, повышающего концентрацию; способ введения лекарства и водный раствор (варианты)
FR2842736B1 (fr) * 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
SI1438960T2 (sl) * 2003-01-14 2013-04-30 Cimex Pharma Ag Sestavek itrakonazola, dispergiranega v hidrofilnem polimeru, z izboljšano biorazpoložljivostjo
DE60312636T3 (de) * 2003-01-14 2014-12-24 Acino Pharma Ag Bioaequivalente Zusammensetzung in der Form einer festen Dispersion enthaltend Itraconazol und ein hydrophiles Polymer
FR2852607B1 (fr) * 2003-03-20 2006-07-14 Procede de fabrication de microspheres de sucre de petite taille, les microspheres susceptibles d'etre obtenues par ce procede et leurs applications
FR2857591B1 (fr) * 2003-07-17 2007-11-02 Ethypharm Sa Particules comprenant un principe actif sous forme de co-precipite
EP1648467B1 (en) 2003-07-17 2018-03-21 Janssen Sciences Ireland UC Process for preparing particles containing an antiviral
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
JP5435946B2 (ja) 2005-08-22 2014-03-05 ジョンズ ホプキンス ユニバーシティ 疾患を処置するためのヘッジホッグ経路アンタゴニスト
CN101283984B (zh) * 2007-04-12 2010-05-26 永胜药品工业股份有限公司 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
CN102781429A (zh) * 2010-03-05 2012-11-14 巴斯夫欧洲公司 经熔体涂覆的药物剂型
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
MA40982A (fr) * 2014-11-19 2017-09-26 Biogen Ma Inc Formulation de bille pharmaceutique comprenant du fumarate de diméthyle
JP2018520114A (ja) * 2015-05-25 2018-07-26 サン ファーマシューティカル インダストリーズ リミテッドＳｕｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｉｎｄｕｓｔｒｉｅｓ Ｌｔｄ． イソトレチノインの１日１回経口医薬組成物
US10137111B2 (en) 2016-08-11 2018-11-27 Adamis Pharmaceuticals Corporation Drug compositions comprising an anti-parasitic and proton pump inhibitor
CA3078723A1 (en) 2016-11-28 2018-05-31 Nachiappan Chidambaram Oral testosterone undecanoate therapy
US11564910B2 (en) 2017-12-08 2023-01-31 Adamis Pharmaceuticals Corporation Drug compositions
WO2019208801A1 (ja) * 2018-04-27 2019-10-31 凸版印刷株式会社 徐放性複合粒子、徐放性複合粒子の製造方法、乾燥粉体及び壁紙
EP4452232A1 (en) * 2021-12-22 2024-10-30 Palau Pharma, S.L.U. Multiparticulate albaconazole composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267179A (en) * 1978-06-23 1981-05-12 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4916134A (en) * 1987-03-25 1990-04-10 Janssen Pharmacuetica N.V. 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
CN1165291C (zh) * 1996-05-20 2004-09-08 詹森药业有限公司 具有改进的生物利用度的抗真菌组合物
CN1121860C (zh) * 1996-05-24 2003-09-24 先灵公司 提高生物利用度的抗真菌组合物
IL127780A0 (en) * 1996-06-28 1999-10-28 Schering Corp Oral compositions comprising a triazole antifungal compound
DE19626924C2 (de) * 1996-07-04 1999-08-19 Epazon B V Gerät zur Bereitstellung eines Atemgases
ES2201485T3 (es) 1997-03-26 2004-03-16 Janssen Pharmaceutica N.V. Palets que tienen un nucleo recubierto con un agente antifungico y un polimero.

Also Published As

Publication number Publication date
BG65187B1 (bg) 2007-06-29
ES2194480T3 (es) 2003-11-16
BR9912300A (pt) 2001-04-17
SK283279B6 (sk) 2003-05-02
DE69905905D1 (de) 2003-04-17
DE69905905T2 (de) 2004-03-04
BG105282A (en) 2001-11-30
NO20010289D0 (no) 2001-01-17
HUP0103708A3 (en) 2002-07-29
NO320054B1 (no) 2005-10-17
CA2337509A1 (en) 2000-02-03
JP2002521323A (ja) 2002-07-16
TR200100177T2 (tr) 2001-07-23
HRP20010128B1 (en) 2003-12-31
NZ509886A (en) 2002-09-27
IL140910A (en) 2004-03-28
RS50063B (sr) 2009-01-22
HU228895B1 (en) 2013-06-28
CZ2001175A3 (en) 2001-05-16
ES2157731B1 (es) 2002-05-01
PL345625A1 (en) 2002-01-02
CZ291938B6 (cs) 2003-06-18
ATE234077T1 (de) 2003-03-15
IL140910A0 (en) 2002-02-10
JP4190732B2 (ja) 2008-12-03
CA2337509C (en) 2005-12-27
HUP0103708A2 (hu) 2002-02-28
NO20010289L (no) 2001-03-07
EE200100041A (et) 2002-06-17
AU750730B2 (en) 2002-07-25
AU4782199A (en) 2000-02-14
ES2157731A1 (es) 2001-08-16
HRP20010128A2 (en) 2002-12-31
PL194740B1 (pl) 2007-06-29
KR100572135B1 (ko) 2006-04-19
PT1103252E (pt) 2003-07-31
RU2209628C2 (ru) 2003-08-10
DK1103252T3 (da) 2003-07-14
EP1103252B1 (en) 2003-03-12
MXPA01000681A (es) 2002-04-24
HK1037531A1 (en) 2002-02-15
SK862001A3 (en) 2001-08-06
KR20010070990A (ko) 2001-07-28
YU3901A (sh) 2003-08-29
WO2000004881A1 (es) 2000-02-03
MEP26708A (en) 2010-06-10
UA64009C2 (en) 2004-02-16
EP1103252A1 (en) 2001-05-30
US6737082B1 (en) 2004-05-18
ZA200101293B (en) 2001-08-21

Similar Documents

Publication Publication Date Title
EE04415B1 (et) Antimükootilist toimet omava ühendi farmatseutiline peroraalne preparaat ja selle valmistamismeetod
DE69935677D1 (de) Antibiotische hydrophile beschichtung
DE69431807D1 (de) Teilchenförmige synthetische Träger sowie Verfahren zu deren Herstellung
CA2314078A1 (en) Coating of polymers
DK76892A (da) Genstand med friktionsnedsaettende overfladebelaegning samt fremgangsmaade til fremstilling af en saadan belagt genstand
CA2348398A1 (en) Water-soluble coating agents bearing initiator groups and coating process
CA2370067A1 (en) Pharmaceutical dosage forms for controlled release producing at least a timed pulse
FI101344B1 (fi) Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseuttisesti aktiivista ainetta
RU2001104894A (ru) Пероральная фармацевтическая композиция на основе соединения, имеющего антигрибковую активность, и способ ее получения
FR2774288B1 (fr) Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques
CA2446712A1 (en) System for osmotic delivery of pharmaceutically active agents
ATE97567T1 (de) Eine suspension hydratisierter spheroide einer hydrophilen lipidsubstanz enthaltendes waessriges kosmetisches bzw. dermopharmazeutisches mittel.
BRPI0407116A (pt) Partìcula revestida baseada em princìpio ativo, composição farmacêutica ou cosmética, e, método para produção de partìcula revestida com princìpio ativo
HK1063017A1 (en) Microgranules based on active principle and methodfor making same
EP0998944A3 (en) Enteric coated formulation of a benzimidazole derivative and method for preparation thereof
HUP0203310A2 (hu) Benzimidazolszármazékot tartalmazó stabil gyógyszerkészítmények és eljárás ezek előállítására
ES8800838A1 (es) Metodo de fabricacion de un nuevo dispositivo distribuidor para la descarga a velocidad controlada de farmacos.
ITRM940715A0 (it) Nuovi 1,5 derivati di 7a-metilperidroinden-3a-oli, attivi sul sistema cardiovascolare, procedimenti per la loro preparazione e composizione farmaceutiche che li contengono
YU31302A (sh) Flaster za produženo lečenje bubuljica i postupak dobijanja

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20140720